Immediate Impact
6 from Science/Nature 51 standout
Citing Papers
Artificial intelligence in drug development
2025 Standout
Mapping the effectiveness and risks of GLP-1 receptor agonists
2025 Standout
Works of Julie Horowitz being referenced
Safety and efficacy of itepekimab in patients with moderate-to-severe COPD: a genetic association study and randomised, double-blind, phase 2a trial
2021
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Julie Horowitz | 144 | 97 | 54 | 82 | 18 | 401 | |
| Vanessa Granger | 253 | 92 | 23 | 80 | 19 | 418 | |
| Hiroaki Ida | 101 | 97 | 47 | 95 | 18 | 344 | |
| Christy A. Tarleton | 167 | 99 | 19 | 94 | 12 | 369 | |
| Harris | 60 | 50 | 59 | 38 | 16 | 407 | |
| Ioannis Théodorou | 313 | 30 | 42 | 38 | 12 | 437 | |
| Emilio Besada | 138 | 63 | 31 | 55 | 27 | 449 | |
| Amanda Jacobson | 210 | 132 | 32 | 42 | 19 | 455 | |
| Muss Hb | 76 | 101 | 24 | 74 | 18 | 452 | |
| Pamela M. Simmons | 104 | 59 | 50 | 79 | 11 | 350 | |
| Anne‐Sophie Bedin | 112 | 44 | 17 | 55 | 17 | 407 |
All Works
Login with ORCID to disown or claim papers
Loading papers...